This website uses cookies and similar technologies to optimize and improve the experience on our website. By continuing to use this website, you agree to the use of cookies and similar technologies as described in our Privacy Policy.
Accept

June 23, 2021

Brii Biosciences and VBI Vaccines Present Positive Data from Completed Phase 1b/2a Study on BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B at the International Liver Congress 2021

June 9, 2021

Brii Biosciences to Present Updated Phase 1b/2a Data on BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B at the International Liver Congress 2021

up
×